We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3

News   Jun 16, 2015

 
MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3
 
 
 

RELATED ARTICLES

Molecule Fights Muscular Paralysis

News

UNIGE researchers have identified a molecule that can halt the progress of a severe genetic disease that causes whole-body muscle paralysis followed by death.

READ MORE

Peanut Allergy Treatment Ready for FDA Review

News

Study shows it is possible for some people with peanut allergy to protect themselves from accidental ingestion by building up their tolerance to peanut over time.

READ MORE

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE